Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 2
2012 6
2013 22
2014 18
2015 11
2016 19
2017 20
2018 13
2019 5
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 30093457

97 results
Results by year
Filters applied: . Clear all
Page 1
Fibroblast Growth Factor-23 May Follow Cardiovascular Disease Rather than Causing It in Chronic Kidney Disease.
Zhou C, Mei C, Dai B, Xue C. Zhou C, et al. J Am Soc Nephrol. 2018 Oct;29(10):2602. doi: 10.1681/ASN.2018050517. Epub 2018 Aug 9. J Am Soc Nephrol. 2018. PMID: 30093457 Free PMC article. No abstract available.
Fibroblast growth factor 23 in chronic kidney disease: what is its role in cardiovascular disease?
Wagner CA, Rubio-Aliaga I, Egli-Spichtig D. Wagner CA, et al. Nephrol Dial Transplant. 2019 Dec 1;34(12):1986-1990. doi: 10.1093/ndt/gfz044. Nephrol Dial Transplant. 2019. PMID: 30903187 No abstract available.
Is Fibroblast Growth Factor 23 the New Biomarker for Cardiovascular Mortality in Chronic Kidney Disease Patients?
Filler G, McIntyre C. Filler G, et al. Am J Nephrol. 2017;45(2):146-148. doi: 10.1159/000454961. Epub 2016 Dec 23. Am J Nephrol. 2017. PMID: 28006763 Free article. No abstract available.
[Fibroblast growth factor 23 in chronic kidney disease in children].
Okarska-Napierała M, Skrzypczyk P, Pańczyk-Tomaszewska M. Okarska-Napierała M, et al. Pol Merkur Lekarski. 2016 Jun;40(240):393-8. Pol Merkur Lekarski. 2016. PMID: 27403909 Review. Polish.
Fibroblast Growth Factor-23 Is Not a Single Bystander in Chronic Kidney Disease Mortality.
Pelletier S, Fouque D. Pelletier S, et al. J Am Soc Nephrol. 2018 Oct;29(10):2601. doi: 10.1681/ASN.2018060583. Epub 2018 Jul 13. J Am Soc Nephrol. 2018. PMID: 30006416 Free PMC article. No abstract available.
Fibroblast growth factor-23 helps explain the biphasic cardiovascular effects of vitamin D in chronic kidney disease.
Hu P, Xuan Q, Hu B, Lu L, Wang J, Qin YH. Hu P, et al. Int J Biol Sci. 2012;8(5):663-71. doi: 10.7150/ijbs.3886. Epub 2012 May 5. Int J Biol Sci. 2012. PMID: 22606047 Free PMC article. Review.
Fibroblast growth factor 23: associations with cardiovascular disease and mortality in chronic kidney disease.
Negri AL. Negri AL. Int Urol Nephrol. 2014 Jan;46(1):9-17. doi: 10.1007/s11255-012-0370-2. Epub 2013 Jan 8. Int Urol Nephrol. 2014. PMID: 23296792 Review.
Fibroblast growth factor-23 and outcomes: new answers, new questions.
Bhan I, Thadhani R. Bhan I, et al. J Am Soc Nephrol. 2013 Mar;24(4):523-5. doi: 10.1681/ASN.2013020169. Epub 2013 Mar 21. J Am Soc Nephrol. 2013. PMID: 23520207 Free article. No abstract available.
FGF23 effects on the heart-levels, time, source, and context matter.
Faul C. Faul C. Kidney Int. 2018 Jul;94(1):7-11. doi: 10.1016/j.kint.2018.03.024. Kidney Int. 2018. PMID: 29933856
Time-averaged level of fibroblast growth factor-23 and clinical events in chronic kidney disease.
Bouma-de Krijger A, Bots ML, Vervloet MG, Blankestijn PJ, Ter Wee PW, van Zuilen AD, Wetzels JF. Bouma-de Krijger A, et al. Nephrol Dial Transplant. 2014 Jan;29(1):88-97. doi: 10.1093/ndt/gft456. Epub 2013 Nov 8. Nephrol Dial Transplant. 2014. PMID: 24215017 Clinical Trial.
97 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback